https://www.healthleadersmedia.com/cfo/cost-control-mirage-what-state-spending-caps-mean-cfos
State health spending growth benchmarks were designed to rein in rising healthcare costs. But a new JAMA Network Open study finds little evidence they have lowered hospital revenue, prices or insurance premiums.
KEY TAKEAWAYS
State benchmarks were not associated with statistically significant reductions in hospital revenue or prices.
Enforcement mechanisms and additional cost-control policies could change the financial equation over time.
Operational efficiency, service-line economics and scenario planning remain essential.
Ambition meets limited results
CFOs have spent years preparing for a policy environment that’s focused on affordability, and state spending growth benchmarks are one response: They set targets for how quickly healthcare spending should grow, with the aim of slowing cost increases without necessarily cutting access to care.
But are these benchmarks actually working?
In a recent study published in JAMA Network Open, researchers from RAND Corporation examined whether state spending growth benchmarks were associated with lower hospital revenue, hospital prices or health insurance premiums. The analysis covered 4,813 hospitals and 3,108 counties, comparing eight states that implemented benchmarks with areas in states without them. The researchers used a case-control design and difference-in-differences models, with up to seven years of postimplementation data for relevant outcomes.
The findings challenge the assumption that setting a spending target will, by itself, produce meaningful cost containment.
Across the study, benchmarks were not associated with statistically significant changes in inpatient hospital revenue per discharge, outpatient revenue per discharge equivalent, standardized inpatient or outpatient prices, or individual- and small-group-market premiums. The estimated changes in these measures were small relative to their uncertainty, and premium findings varied over time rather than demonstrating sustained reductions. Rhode Island was an exception for outpatient prices, where researchers identified a statistically significant reduction.
The central finding: Establishing a benchmark is not the same as changing the financial incentives that drive healthcare spending. The researchers point to limited enforcement and the absence of complementary policies as possible explanations. Of the eight states analyzed, only Vermont, Oregon and California had enforcement mechanisms, and California’s program was too new to provide much evidence on hospital outcomes.
Of course these results do not prove that benchmarks can never work. Differences in implementation, limited follow-up for some states and other policy changes complicate the picture. But still, the study offers little support for expecting benchmarks alone to generate near-term savings.
The CFO To Do
Treat spending benchmarks as a regulatory constraint to monitor, not a savings plan to underwrite.
First, build state-specific scenarios into multiyear financial planning. Model what happens if revenue and commercial prices continue along current trajectories, if regulators intensify scrutiny, or if future enforcement imposes corrective plans or penalties. Avoid assuming that affordability initiatives will automatically reduce market prices—or that existing pricing power will remain untouched.
Second, focus on controllable economics. Strengthen service-line contribution-margin analysis, evaluate labor and supply costs, improve capacity utilization and scrutinize low-margin contracts. If policymakers eventually impose tighter limits, organizations with a clear understanding of their underlying cost structures will be better positioned to respond without indiscriminate cuts.
Third, elevate regulatory intelligence as a finance function. CFOs should work with government affairs, managed-care contracting, and strategy teams to track benchmark performance, enforcement rules and emerging state-level reforms. Market-entry decisions, capital investments and acquisition models should reflect the possibility that today’s voluntary targets become tomorrow’s enforceable requirements.
Finally, distinguish revenue protection from genuine cost transformation. Don’t only think about preserving prices, but build a financially resilient delivery system that can sustain quality and access under tighter affordability expectations.
Policy targets alone have not demonstrated reliable cost containment, so CFOs should prepare for regulation to evolve while making their organizations less dependent on continued price growth to protect margins.
